Sort
21,453 grants matching “tuberculosis”
COMPLICATIONS OF HIV DISEASE AGENDA
$172,411Tulane University Of Louisiana · U01 · FY2002 · AI
COMPLICATIONS OF HIV DISEASE AGENDA
$172,411Tulane University Of Louisiana · U01 · FY2001 · AI
CNS Involvement in the HIV Population in Ethiopia: A Post-mortem Forensic Study
$172,401Teresa Dianne Langford · Temple Univ Of The Commonwealth · R21 · FY2007 · NS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$172,286Denise Ingman · Montana St Dept Of Hlth & Envrnmtl Scis · U52 · FY2007 · PS
Emory-Georgia TB Research Training Program
$172,186Henry M Blumberg · Emory University · D43 · FY2009 · TW
Administrative Core
$172,164Jeffrey H Samet · Boston Medical Center · P01 · FY2024 · AA
BU Clinical HIV/AIDS Research Training Program
$172,120C Robert Horsburgh · Boston Medical Center · T32 · FY2016 · AI
Measuring Real-Time Influences of Mental and Tangible Resources on Men's TB Treatment Lapses and Adherence Behaviors
$172,079Andrew Medina-Marino · Desmond Tutu Hiv Foundation · R21 · FY2021 · AI
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
$172,006Kohta Saito · Weill Medical Coll Of Cornell Univ · K08 · FY2023 · AI
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
$172,006Kohta Saito · Weill Medical Coll Of Cornell Univ · K08 · FY2019 · AI
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
$172,006Kohta Saito · Weill Medical Coll Of Cornell Univ · K08 · FY2021 · AI
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
$172,006Kohta Saito · Weill Medical Coll Of Cornell Univ · K08 · FY2020 · AI
Identifying the Molecular Target of Two Novel Compounds Active Against Non-replicating Mycobacterium tuberculosis and Delineating the Role of the Putative Target, InhA, in Non-replicating States
$172,006Kohta Saito · Weill Medical Coll Of Cornell Univ · K08 · FY2022 · AI
Mentoring patient-oriented translational research in tuberculosis
$171,924Jason Randolph Andrews · Stanford University · K24 · FY2024 · AI
Integrated Point of Care Nucleic Acid Testing for Acute Dengue Virus Infection
$171,896Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R21 · FY2019 · AI
Maximizing Investigators' Research Award (R35)
$171,876Laura Forsberg White · Boston University Medical Campus · R35 · FY2021 · GM
The role of regulatory T cells in M. tuberculosis infection
$171,875Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R21 · FY2009 · AI
NK cells and IL-15 in the human innate immune response to tuberculosis
$171,875Peter F. Barnes · University Of Texas Hlth Ctr At Tyler · R21 · FY2008 · HL
Use of Gallium to Prevent Pseudomonas Biofilm Formation
$171,813University Of Cincinnati · R21 · FY2004 · AI
Pulmonary Pathogen Defense Mechanisms
$171,806Case Western Reserve University · T32 · FY2005 · HL
Task-Shifting Pediatric TB/HIV Prevention to Community Health Workers in South Africa
$171,720Nicole Salazar-Austin · Johns Hopkins University · K23 · FY2022 · HD
DSpace: Utilizing Data Science to Predict and Improve Health Outcomes in Pediatric HIV
$171,714Gaone Retshabile · University Of Botswana · U01 · FY2025 · HD
Clinical Phenotyping: Pediatric HIV and TB Cohort
$171,653Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2017 · AI
Molecular mechanisms of TB exposure outcomes among HIV-infected children
$171,653Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2017 · AI
Persistent Systemic Infection of Mice by Salmonella Enterica
$171,650Corrella Detweiler · University Of Colorado · R01 · FY2009 · AI